|
Client Needs Prioritize technologies: Incubator wanted to prioritize among 8 emerging biomedical technologies including medical devices, pharmaceutical compounds and biologics, those with the highest probability for successful commercialization. A regional biomedical research institute with early development stage technologies retained Strategy Inc. to determine which technologies would deliver the highest return. The institute's management desired to prioritize limited resources and also wanted to use their influence to shine the limelight on those technologies slated for success. The analysis was further compounded by the fact that the portfolio included medical devices, pharmaceutical compounds and biologics from the earliest concept state in a range up to those that already had clinical data.
Product Delivered: TechSelect
Read more...
|
|
Client Needs: Sell their companyA venture funded medical device startup company wanted to sell their technology. The company had minimal clinical data; however the technology was positioned to drive a paradigm shift in clinical treatment. This company retained Strategy Inc.'s services to perform a market assessment and valuation to support their negotiations to obtain a robust and defensible acquisition price of their emerging technology.
Product Delivered: Valuation
Read more...
|
|
Client Needs: Determine worldwide market opportunity for new medical device
The business development team of a leading global developer, manufacturer and marketer of medical devices retained Strategy Inc. to determine the market opportunity for an expanded market. The project included recommendations for business development efforts and financial projections for emerging target markets including Japan and China.
Product Delivered: International Market Analysis
Read more... |
|
Client Needs: Platform technology with 11 potential indications for use: Determining the best business opportunity
A developer, manufacturer and marketer of state-of-the-art high tech medical devices retained Strategy Inc.'s services to analyze worldwide opportunities of a platform implantable technology. The company desired increased revenues and desired to leverage of the developing implantable platform technology with expanded indications. To ensure that product development, regulatory, and executive staff resources would be allocated to business opportunities with the highest probability of commercial success, an analysis was performed on 11 potential expanded indications for use at the direction of the Vice President, Emerging Indications.
Product Delivered: Comparative Analysis of Platform Technology
Read more... |
|
Client Needs: Prioritize which university-based technology should receive additional development funding
A university-based non-profit institute founded to support development and commercialization of compelling medical devices more rapidly to patients retained Strategy Inc.'s services to help provide a framework for business focused decision making. This was accomplished through robust analysis of the worldwide market opportunities for several emerging technologies.
Product Delivered: Technology Assessment
Read more... |
